12.07.2015 Views

PEDIATRIA CATALANA - Societat Catalana de Pediatria

PEDIATRIA CATALANA - Societat Catalana de Pediatria

PEDIATRIA CATALANA - Societat Catalana de Pediatria

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Els pediatres <strong>de</strong> Catalunya presenten fora40. González Tomé M, Ramos Amador J, Guillén Martín S, Muñoz GallegoE, Sánchez Granados J, Solís Villamarzo I, Ruiz Contreras J. Evolución<strong>de</strong> la transmisión vertical y factores involucrados. An Españ Pediatr(Barc) 2005; 62 (1): 25-31.41. Infección por VIH y SIDA en España. Plan multisectorial 2001-2005.Plan nacional sobre el SIDA. Madrid: Dirección General <strong>de</strong> Salud, Ministerio<strong>de</strong> Sanidad y Consumo.42. Peña JM. Transmisión vertical <strong>de</strong>l VIH-1. ¿Hasta dón<strong>de</strong> se pue<strong>de</strong> reducir?Med Clín (Barc) 2000; 114: 297-298.43. European Collaborative Study. Mother-to-child transmission of HIV. Infectionin the era of HART. Clin Infect Dis 2005; 40: 458-465.44. Watts DH, Balasubramanian R, Maupin RT, Delke I, Dorenbaum A,Fiore S, et al (for the PACTG Team). Maternal Toxicity and PregnancyComplications in Women Receiving Antiretroviral Therapy. Am J ObstetGynecol 2004; 190(2): 506-516.45. Recomendations for use of antiretroviral drugs in pregnant HIV-1 infectetwomen for maternal health and interventions to reduce perinatalHIV-1 transmission in the United States. Washington: Public HealthService Task Force 2005.46. Ochoa Sangrador C, Orejón <strong>de</strong> Luna G. Los cambios en el manejo <strong>de</strong>la embarazada con infección por virus <strong>de</strong> la inmuno<strong>de</strong>ficiencia humanaen la última década pue<strong>de</strong>n evitar su transmisión vertical. Evid Pediatr2007; vol. 3, 2.47. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immuno<strong>de</strong>ficiencyvirus type 1 RNA levels in blood and the female genitaltract. J Infect Dis 1999; 179: 871-882.48. Matheson PB, Abrams EJ, Thomas P, Hernan MA, Thea DM, LambertG, et al. Efficacy of antenatal zidovudine in reducing perinatal transmissionof human immuno<strong>de</strong>ficiency virus type 1. J Infect Dis 1995;172: 353-358.49. Alexio LF, Goo<strong>de</strong>now MM, Sleasman JW. Zidovudine administredto women infected with human immuno<strong>de</strong>ficiency virus type 1 and totheir neonates reduces pediatric infection in<strong>de</strong>pen<strong>de</strong>nt of an effect onlevels of maternal virus. J Pediatr 1997; 130: 906-914.50. European Collaborative Study. Combination antiretroviral therapy andduration of pregnancy. Swiss mother and child HIV cohort study. AIDS2001; 15: 1.195-1.196.51. Iribarren JA, Ramos JT, Guerra L, Coll O, De José MI, Domingo P, et al.Prevention of vertical transmission and treatment of infection causedby the human immuno<strong>de</strong>ficiency virus in the pregnant woman. Recommendationsof the Study group for AIDS, Infectious Diseases, andClinical and Microbiology, the Spanish Pediatric Association, the NationalAIDS Plan and the Spanish Gynecology and Obstetrics Society.Enf Infecc Microbiol Clín 2001; 314-335.52. Shaffer N, Bulterys M, Simonds RJ. Short courses of zidovudina andperinatal transmission of HIV. N Engl J Med 1999; 340: 1.042-1.043.53. Coutsoudis A, Pillary K, Spooner E, Kuhn L, Coovadia HM, et al. Influenceof infant feeding patterns on early mother-to-child transmissionof HIV-1 infection. Lancet 1999; 354: 471-476.54. Temmerman M, Nyong’o AO, Brawo J, Fransen K, Coopens M, Piot P.Risk factors for mother to child transmission of HIV-1 infection. Am JObstet Gynecol 1995; 171: 1.372-1.381.55. Perneger TV. What’s wrong with Bonferroni adjustments. British MedicalJournal 1998; 316: 1.236-1.238.<strong>PEDIATRIA</strong> <strong>CATALANA</strong> Any 2011 Volum 71S35

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!